Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2504544rdf:typepubmed:Citationlld:pubmed
pubmed-article:2504544lifeskim:mentionsumls-concept:C0085251lld:lifeskim
pubmed-article:2504544lifeskim:mentionsumls-concept:C0559546lld:lifeskim
pubmed-article:2504544lifeskim:mentionsumls-concept:C1549114lld:lifeskim
pubmed-article:2504544pubmed:issue3lld:pubmed
pubmed-article:2504544pubmed:dateCreated1989-9-29lld:pubmed
pubmed-article:2504544pubmed:abstractTextWe describe a patient with recurrent atrial fibrillation who suffered a previously unreported adverse reaction to encainide therapy manifested by fever, chills, diaphoresis and myalgia. The patient had a similar response upon rechallenging with encainide, which resolved on discontinuation of therapy.lld:pubmed
pubmed-article:2504544pubmed:languageenglld:pubmed
pubmed-article:2504544pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2504544pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2504544pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2504544pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2504544pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2504544pubmed:statusMEDLINElld:pubmed
pubmed-article:2504544pubmed:monthSeplld:pubmed
pubmed-article:2504544pubmed:issn0012-3692lld:pubmed
pubmed-article:2504544pubmed:authorpubmed-author:NaimEElld:pubmed
pubmed-article:2504544pubmed:authorpubmed-author:NairC KCKlld:pubmed
pubmed-article:2504544pubmed:authorpubmed-author:SketchM HMHSrlld:pubmed
pubmed-article:2504544pubmed:authorpubmed-author:Goli-BijankiR...lld:pubmed
pubmed-article:2504544pubmed:issnTypePrintlld:pubmed
pubmed-article:2504544pubmed:volume96lld:pubmed
pubmed-article:2504544pubmed:ownerNLMlld:pubmed
pubmed-article:2504544pubmed:authorsCompleteYlld:pubmed
pubmed-article:2504544pubmed:pagination688-9lld:pubmed
pubmed-article:2504544pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:meshHeadingpubmed-meshheading:2504544-...lld:pubmed
pubmed-article:2504544pubmed:year1989lld:pubmed
pubmed-article:2504544pubmed:articleTitlePreviously unreported adverse reaction to encainide.lld:pubmed
pubmed-article:2504544pubmed:affiliationDivision of Cardiology and Allergy-Immunology, Creighton University School of Medicine, Omaha, NE.lld:pubmed
pubmed-article:2504544pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2504544pubmed:publicationTypeCase Reportslld:pubmed